Literature DB >> 29588750

Double Chronic Total Occlusion Recanalisation with Antegrade and Retrograde Techniques and the Use of a Novel Drug-eluting Stent with Biodegradable Polymer.

Nikolaos V Konstantinidis1, Georgios Sianos1.   

Abstract

Percutaneous recanalisation of coronary chronic total occlusions (CTOs) has proved an efficient and safe treatment option with steadily ascending success rates, especially since the advent and constant refinement of the retrograde approach. Uptake remains low, even though experienced operators have in the last five years reached an unprecedented maturity level, producing success rates in the range of 90 %, clearly comparable to non-occlusive coronary artery disease treatment. Antegrade and retrograde techniques are currently considered complementary components of a CTO procedure, rather than discrete treatment strategies. We report on the case of a successful CTO recanalisation procedure on a young patient with two chronically occluded coronary arteries and a large ischaemic burden. Both CTOs were addressed in the same session employing a range of dedicated CTO recanalisation techniques, without compromising on safety issues related to contrast dye consumption and radiation exposure. A novel drug-eluting stent (DES) with biodegradable polymer was used to treat the lesions.

Entities:  

Keywords:  CORACTO stent; CTO recanalisation; Chronic total occlusion; biodegradable polymer; drug-eluting stents; percutaneous coronary intervention

Year:  2013        PMID: 29588750      PMCID: PMC5808694          DOI: 10.15420/icr.2013.8.1.46

Source DB:  PubMed          Journal:  Interv Cardiol        ISSN: 1756-1485


  21 in total

1.  CTO PCI at the crossroads.

Authors:  Georgios Sianos
Journal:  EuroIntervention       Date:  2010-08       Impact factor: 6.534

Review 2.  Recanalisation of chronic total coronary occlusions: 2012 consensus document from the EuroCTO club.

Authors:  Georgios Sianos; Gerald S Werner; Alfredo R Galassi; Michail I Papafaklis; Javier Escaned; David Hildick-Smith; Evald Høj Christiansen; Anthony Gershlick; Mauro Carlino; Angelos Karlas; Nikolaos V Konstantinidis; Salvatore D Tomasello; Carlo Di Mario; Nicolaus Reifart
Journal:  EuroIntervention       Date:  2012-05-15       Impact factor: 6.534

3.  Recent trends in the percutaneous treatment of chronic total coronary occlusions.

Authors:  J Dawn Abbott; Kevin E Kip; Helen A Vlachos; Neil Sawhney; Vankeepuran S Srinivas; Alice K Jacobs; David R Holmes; David O Williams
Journal:  Am J Cardiol       Date:  2006-04-21       Impact factor: 2.778

4.  Angiographic assessment of collateral connections in comparison with invasively determined collateral function in chronic coronary occlusions.

Authors:  Gerald S Werner; Markus Ferrari; Stephan Heinke; Friedhelm Kuethe; Ralf Surber; Barbara M Richartz; Hans R Figulla
Journal:  Circulation       Date:  2003-03-24       Impact factor: 29.690

Review 5.  Efficacy and safety of drug-eluting stents in chronic total coronary occlusion recanalization: a systematic review and meta-analysis.

Authors:  Humberto J Colmenarez; Javier Escaned; Cristina Fernández; Liliana Lobo; Sara Cano; Juan G del Angel; Fernando Alfonso; Pilar Jimenez; Camino Bañuelos; Nieves Gonzalo; Eulogio García; Rosana Hernández; Carlos Macaya
Journal:  J Am Coll Cardiol       Date:  2010-04-27       Impact factor: 24.094

6.  Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: data from a multicenter, prospective, observational study (TOAST-GISE).

Authors:  Zoran Olivari; Paolo Rubartelli; Federico Piscione; Federica Ettori; Alessandro Fontanelli; Luigi Salemme; Corinna Giachero; Carlo Di Mario; Gabriele Gabrielli; Leonardo Spedicato; Francesco Bedogni
Journal:  J Am Coll Cardiol       Date:  2003-05-21       Impact factor: 24.094

7.  European experience with the retrograde approach for the recanalisation of coronary artery chronic total occlusions. A report on behalf of the euroCTO club.

Authors:  Georgios Sianos; Peter Barlis; Carlo Di Mario; Michail I Papafaklis; Joachim Büttner; Alfredo R Galassi; Joachim Schofer; Gerald Werner; Thierry Lefevre; Yves Louvard; Patrick W Serruys; Nicolaus Reifart
Journal:  EuroIntervention       Date:  2008-05       Impact factor: 6.534

8.  Clinical and angiographic outcomes with sirolimus-eluting stents in total coronary occlusions: the ACROSS/TOSCA-4 (Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4) trial.

Authors:  David E Kandzari; Sunil V Rao; Jeffrey W Moses; Vladimir Dzavik; Bradley H Strauss; Michael J Kutryk; Charles A Simonton; Jyotsna Garg; Yuliya Lokhnygina; G B John Mancini; Eunice Yeoh; Christopher E Buller
Journal:  JACC Cardiovasc Interv       Date:  2009-02       Impact factor: 11.195

9.  Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy.

Authors:  Leslee J Shaw; Daniel S Berman; David J Maron; G B John Mancini; Sean W Hayes; Pamela M Hartigan; William S Weintraub; Robert A O'Rourke; Marcin Dada; John A Spertus; Bernard R Chaitman; John Friedman; Piotr Slomka; Gary V Heller; Guido Germano; Gilbert Gosselin; Peter Berger; William J Kostuk; Ronald G Schwartz; Merill Knudtson; Emir Veledar; Eric R Bates; Benjamin McCallister; Koon K Teo; William E Boden
Journal:  Circulation       Date:  2008-02-11       Impact factor: 29.690

10.  Retrograde percutaneous recanalization of chronic total occlusion of the coronary arteries: procedural outcomes and predictors of success in contemporary practice.

Authors:  Sudhir Rathore; Osamu Katoh; Hitoshi Matsuo; Mitsuyasu Terashima; Nobuyoshi Tanaka; Yoshihisa Kinoshita; Masashi Kimura; Etsuo Tsuchikane; Kenya Nasu; Mariko Ehara; Keiko Asakura; Yasushi Asakura; Takahiko Suzuki
Journal:  Circ Cardiovasc Interv       Date:  2009-02-20       Impact factor: 6.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.